HIV in the News

Published on: May 17, 2019
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
Published on: May 17, 2019
Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.
Published on: May 17, 2019
Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.
Published on: May 16, 2019
Especially when charities still rely on the star-studded Vienna event.
Published on: May 16, 2019
Especially when charities still rely on the star-studded Vienna event.
Published on: May 15, 2019
A member of ACT UP and Rise and Resist, Vélez fought for drug access and civil rights, notably for those in the Latino community.
Published on: May 15, 2019
A member of ACT UP and Rise and Resist, Vélez fought for drug access and civil rights, notably for those in the Latino community.
Published on: May 14, 2019
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
Published on: May 14, 2019
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
Published on: May 14, 2019
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.

Pages